Bayban’s Procept Biorobotics PRCT Stock Holding History
Bought
Maintained
Sold
Other funds holding PRCT
Bayban's PRCT Position: Q3 2026 in Review
Bayban sold out of Procept Biorobotics (PRCT) in Q3 2026, closing a stake of 20 shares — an estimated $452 sold.
Bayban first reported a position in PRCT in Q4 2025 and held it in 3 quarters. The position peaked at $629 in Q4 2025. 232 funds tracked by Wall St. Rank hold PRCT as of Q3 2026.
- Bayban reported no remaining Procept Biorobotics position as of Q3 2026 after selling out during the quarter.
- Bayban sold 20 Procept Biorobotics shares in Q3 2026, an estimated $452.
- Bayban first reported a position in Procept Biorobotics in Q4 2025 and held it in 3 quarters.
- Bayban's Procept Biorobotics position peaked at $629 in Q4 2025.
- 232 funds tracked by Wall St. Rank held Procept Biorobotics as of Q3 2026.
Based on Bayban's 13F filing for Q3 2026, filed 5 Nov 2026.